Clinical Safety

Addressing Off-Target Risks in CRISPR Genome Editing
Research & Development Addressing Off-Target Risks in CRISPR Genome Editing

While the Cas9 protein effectively targets specific DNA sequences, its inherent biochemical flexibility allows for unintended cleavage at genomic sites that closely resemble the intended target. This fundamental challenge persists even as the medical community celebrates the clinical success of

Australia to Allow Telehealth Follow-Ups for Medication Reviews
Tech & Innovation Australia to Allow Telehealth Follow-Ups for Medication Reviews

The inclusion of telehealth follow-ups facilitates the participation of family members and caregivers who might not be available for traditional mid-day home visits. This regulatory update, which takes effect on November 1, represents a landmark shift in Australian pharmacy practice by allowing

Can Metallic Nanoparticles Solve the Antibiotic Crisis?
Research & Development Can Metallic Nanoparticles Solve the Antibiotic Crisis?

Small-scale nanoparticles are uniquely capable of penetrating the dense architecture of biofilms to disrupt the quorum sensing communication that bacteria use to maintain their survival. This revelation comes at a time when the global medical community is facing a significant crossroads, as the

Therapeutic Ultrasound Mechanisms in Skin Repair and Regeneration
Tech & Innovation Therapeutic Ultrasound Mechanisms in Skin Repair and Regeneration

Addressing the chronic ischemia found in diabetic ulcers requires the upregulation of vascular endothelial growth factor, a process achievable through ultrasound-microbubble therapy. The skin functions as a highly sophisticated, multi-layered organ that maintains a constant state of flux, balancing

What Are the Global Trends in Biorisk Management?
Management & Regulatory What Are the Global Trends in Biorisk Management?

The rapid evolution of biotechnological capabilities has brought humanity to a critical juncture where the potential for life-saving discoveries is matched by the escalating complexity of biological threats. Effective biorisk governance requires a structured institutional architecture that moves

Can G-Quadruplex Targeting Finally Silencing c-MYC?
Research & Development Can G-Quadruplex Targeting Finally Silencing c-MYC?

Genetic blueprints have long been visualized as sleek, predictable spirals, yet the hidden reality of our DNA involves complex architectural knots that could hold the secret to dismantling the most aggressive forms of human cancer. While the Watson-Crick double helix remains the foundation of

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later